Is PRTC.L up or down today?
PRTC.L is up 0.46% today, last at 221.59. This stock moved +0.46% versus the prior close.
PRTC.L · PRTC.L
PRTC.L (PRTC.L) is trading at 221.59, up 0.46% on the session. PRTC.L sits at the 50% mark of its 52-week range, carries a 14-day RSI of 46, and trades above its 50-day average. Over the past month it is down 1.86%.
Leading the coverage: “RCS - PureTech Health PLC - PRTC's Celea:2 Deupirfenidone Presentations at ERS - TradingView” (Google News Company, 14d ago). PRTC.L is -0.79% since story.
PRTC.L trades on a trailing P/E of 17.5 and is running 2.07% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
PRTC.L is up 0.46% today, last at 221.59. This stock moved +0.46% versus the prior close.
Leading the coverage: “RCS - PureTech Health PLC - PRTC's Celea:2 Deupirfenidone Presentations at ERS - TradingView” (Google News Company, 14d ago). PRTC.L is -0.79% since story. Dominant story: RCS - PureTech Health PLC - PRTC's Celea:2 Deupirfenidone Presentations at ERS - TradingView (1 source, neutral) RSI is 46 — neutral Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (181 days) · Drag or scroll left for earlier dates
RCS - PureTech Health PLC - PRTC's Celea:2 Deupirfenidone Presentations at ERS - TradingView
PRTC Stock Price and Chart — LSE:PRTC - TradingView
PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations - DirectorsTalk Interviews
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO
PureTech Health H2 Earnings Call Highlights